open access

Vol 2, No 2 (1997)
Untitled
Published online: 1997-01-01
Submitted:
Get Citation

Some clinical applications of MTS-type TLD detectors

M. Waligórski, J. Lesiak, T. Byrski, P. Olko, P. Bilski
DOI: 10.1016/S1428-2267(97)70151-0
·
Rep Pract Oncol Radiother 1997;2(2):62.

open access

Vol 2, No 2 (1997)
Untitled
Published online: 1997-01-01
Submitted:

Abstract

An important part of any QA programme for radiotherapy is verification, in vitro or in vivo, of calculated doses and dose distributions. We studied the clinical applicability of LiF:MG, Ti sintered TL detectors produced, as type MTS-N, by the Institute of Nuclear Physics in Kraków (INP). These are solid pellets of diam 4.5mm and 0.8mm thickness. The TL reader was a modified planchet-type 770A, also produced at the INP, with linear heating and computerised glow curve recording.

For analysis of in vivo applications, we measured, in a water phantom, the dose at 14 points aroud the Standard gynaecological applicator of our SELECTRON LDR/MDR afterloading unit with Cs-137 pellets and compared the measured values with doses calculated at these points by the in-house developed SELKOM computer code used for planning gynaecological brachytherapy at the Centre of Oncology in Kraków (COK). Agreement to within 5% was stated.

To demonstrate the applicability of MTS dosemeters in calibration dosimetry, we studied the accuracy, stability and reproducibility of a batch of 100 detectors over several readout cycles at doses ranging from 0.5 to 2.5 Gy. At 1 Gy, the relative standard deviation of Individual Calibration Factors (ICF) over six readout cycles did not exceed 2.5% indicating that the error of dose estimation using individual MTS detectors should not exceed 2%.

In an intercomparison of Co-60 beams at the COK and at Louvain performed with MTS detectors agreement to within less than 0.5% was found with an accuracy better than 1%.

This work is partly supported by KBN Polish State Committee for Scientific Research, Research Project No. 8T11E02908.

Abstract

An important part of any QA programme for radiotherapy is verification, in vitro or in vivo, of calculated doses and dose distributions. We studied the clinical applicability of LiF:MG, Ti sintered TL detectors produced, as type MTS-N, by the Institute of Nuclear Physics in Kraków (INP). These are solid pellets of diam 4.5mm and 0.8mm thickness. The TL reader was a modified planchet-type 770A, also produced at the INP, with linear heating and computerised glow curve recording.

For analysis of in vivo applications, we measured, in a water phantom, the dose at 14 points aroud the Standard gynaecological applicator of our SELECTRON LDR/MDR afterloading unit with Cs-137 pellets and compared the measured values with doses calculated at these points by the in-house developed SELKOM computer code used for planning gynaecological brachytherapy at the Centre of Oncology in Kraków (COK). Agreement to within 5% was stated.

To demonstrate the applicability of MTS dosemeters in calibration dosimetry, we studied the accuracy, stability and reproducibility of a batch of 100 detectors over several readout cycles at doses ranging from 0.5 to 2.5 Gy. At 1 Gy, the relative standard deviation of Individual Calibration Factors (ICF) over six readout cycles did not exceed 2.5% indicating that the error of dose estimation using individual MTS detectors should not exceed 2%.

In an intercomparison of Co-60 beams at the COK and at Louvain performed with MTS detectors agreement to within less than 0.5% was found with an accuracy better than 1%.

This work is partly supported by KBN Polish State Committee for Scientific Research, Research Project No. 8T11E02908.

Get Citation
About this article
Title

Some clinical applications of MTS-type TLD detectors

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 2, No 2 (1997)

Pages

62

Published online

1997-01-01

DOI

10.1016/S1428-2267(97)70151-0

Bibliographic record

Rep Pract Oncol Radiother 1997;2(2):62.

Authors

M. Waligórski
J. Lesiak
T. Byrski
P. Olko
P. Bilski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl